add

Tuesday, February 26, 2019

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

No comments:

Post a Comment

Samsung Executive Reportedly Confirms Exynos 2700 Development for Upcoming Flagship Phones

Samsung Galaxy S27 series, the rumoured successor to this year’s Galaxy S26 lineup, is expected to be launched in select global markets, inc...